Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update
Positive 270-day Interim Clinical Study Data for the First Subject and Positive 180-day Interim Clinical Study Data for the Second Subject ...
Pharmabiz11h
Eupraxia Pharma reports positive data from RESOLVE phase 1b/2a trial of EP-104GI for treatment of eosinophilic esophagitis
Victoria, British Columbia Thursday, November 14, 2024, 18:00 Hrs [IST] ...
BlackDoctor2d
Dysphagia Due to Crohn’s? Here’s What to Do
It can make it difficult to eat certain foods, difficult to get adequate nutrients, and generally just difficult to function ...
Eupraxia Pharmaceuticals Announces Positive Data From Fifth Cohort Of RESOLVE Phase 1B/2A Trial Of EP-104GI For Treatment Of Eosinophilic Esophagitis
One of three patients in Cohort 5 achieved complete histological remission at 12 weeks. <li /> Consistent improve ...